| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/26/2008 | CA2490299C Pharmaceutical composition for controlled release of active substances and the manufacturing method thereof |
| 08/26/2008 | CA2432129C Pyrazole compounds useful as protein kinase inhibitors |
| 08/26/2008 | CA2361614C Compositions for treating inflammatory response |
| 08/26/2008 | CA2347110C A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid |
| 08/21/2008 | WO2008101098A2 Use of botulinum toxin and enzymes for treating bladder or prostata disorders, or hyperhydrosis |
| 08/21/2008 | WO2008099912A1 5ht4 receptor antagonist |
| 08/21/2008 | WO2008099907A1 Therapeutic agent for urinary excretion disorder |
| 08/21/2008 | US20080200552 side effect reduction; bone disease and psoriasis; compounds display the desirable cell differentiation and antiproliferative effects with reduced calcium mobilization; 2-(4-{1-Ethyl-1-[4-(1-hydroxy-cyclopentylethynyl)-3-methyl-phenyl]-propyl}-2-methyl-benzoylamino)-2-methyl-propionic acid |
| 08/21/2008 | US20080200524 Treating pain, inflammation and traumatic injury; using 2-pyridinyl-phenyl-4-amido-p-sulfono or sulfonamidobenzene derivatives |
| 08/21/2008 | US20080200494 Imidazopyridine Derivatives |
| 08/21/2008 | US20080199452 Botulinum toxin compositions and methods |
| 08/21/2008 | DE102005005397B4 Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms Isolation of N-butyl benzene, synthesis of benzenesulfonamide derivatives as well as using N-butyl benzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostatic hyperplasia and / or prostate carcinoma |
| 08/21/2008 | CA2677769A1 Therapeutic agent for urinary excretion disorder |
| 08/20/2008 | EP1957464A1 INDAZOLE DERIVATIVES THAT INHIBIT TRPVl RECEPTOR |
| 08/20/2008 | EP1957451A1 Soft anticholinergic zwitterions |
| 08/20/2008 | EP1692129B1 Keto lactam compounds and use thereof |
| 08/20/2008 | EP1556488B1 Hf-chondroosteomodulin, production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 08/20/2008 | EP1547605B1 Adsorbents for oral administration |
| 08/20/2008 | EP1509521B1 1h-imidazo[4,5-c]quinoline derivatives for the treatment of protein kinase dependent diseases |
| 08/20/2008 | EP1456203B1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 08/20/2008 | EP1289993B9 Caspase inhibitors and uses thereof |
| 08/20/2008 | EP1105111B1 Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder |
| 08/20/2008 | EP1075493B1 Dna encoding snorf25 receptor |
| 08/20/2008 | EP0703897B1 Lipoxin compounds with prolonged half-life |
| 08/20/2008 | CN101247803A Use of a steroid sulphatase inhibitor for inhibiting the synthesis of androstenedione and/or testosterone |
| 08/20/2008 | CN101244274A Ferrite/bacille calmette-guerin vaccine/temperature sensing gel rubber integration material and preparation thereof |
| 08/20/2008 | CN101244240A Quality control method for four turmeric soup preparations |
| 08/20/2008 | CN101244236A Compound preparation for preventing and controlling chronic renal failure heart reconstruction and preparation thereof |
| 08/20/2008 | CN101244227A Chinese medicine pill mainly for treating nephropathy and preparation thereof |
| 08/20/2008 | CN101244219A Chinese medicine powder medicine for treating prostate gland |
| 08/20/2008 | CN101244217A Medicament for treating kidney disease |
| 08/20/2008 | CN101244167A Medicament for treating chronic kidney disease proteinuria and preparation thereof |
| 08/20/2008 | CN101244166A Method of preparing Chinese medicine for treating acute pyelonephritis of adults |
| 08/20/2008 | CN101244165A Tablet for treating damp-heat gonorrhoea and preparation thereof |
| 08/20/2008 | CN101244149A Chinese medicine pill for treating hypertrophy of the prostate and acute chronic prostatitis |
| 08/20/2008 | CN101244121A Leonurus heterophyllus total alkaloid extract and preparation thereof |
| 08/20/2008 | CN101244060A Leonurus heterophyllus alkaloid composition and method of preparing the same |
| 08/20/2008 | CN101244056A Combination capable of preventing prostate gland cancer |
| 08/20/2008 | CN100412073C Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 08/20/2008 | CN100411630C Oral adsorbing agent and medicinal composition containing same |
| 08/20/2008 | CN100411620C Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/19/2008 | US7414122 host cell, viral vector; agonists and antagonists; diagnosis or treatment of cancer; antiproliferative; infertility, miscarriage, preterm labor and delivery, and endometriosis; immunosuppressants; vaccine adjuvants; genetic mapping |
| 08/19/2008 | US7414107 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 08/19/2008 | US7414072 Aryl 5-thio-β-d-glucopyranoside derivatives and therapeutic agents for diabetes containing the same |
| 08/19/2008 | US7414054 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/19/2008 | US7413754 Administering a photoestrogen for treating urinary bladder infection and dry vagina; plant extracts is obtained from solvent extraction |
| 08/19/2008 | CA2468708C Formulations comprising a cephalosporin compound and their use treating bacterial infections in cats and dogs |
| 08/19/2008 | CA2461567C Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 08/19/2008 | CA2432799C Pyrazole compounds useful as protein kinase inhibitors |
| 08/19/2008 | CA2120731C Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 08/14/2008 | WO2008096870A1 Aza-bridged-ring compound |
| 08/14/2008 | WO2008096865A1 Therapeutic agent for disease induced by dysfunction or degeneration of organ |
| 08/14/2008 | WO2008096829A1 Tricyclic compounds |
| 08/14/2008 | WO2008096769A1 Pharmaceutical compositions containing substituted cercosporamide derivatives |
| 08/14/2008 | WO2008096755A1 Vanilloid receptor (vr1) inhibitor and use thereof |
| 08/14/2008 | WO2008096129A1 Nitrogen containing hetrocyclic compounds useful as bifunctional modulators of m3 receptors and beta- 2 receptors |
| 08/14/2008 | WO2008075173A3 Methods for treating podocyte-related disorders |
| 08/14/2008 | US20080194710 Prostatic Stem Cells, Isolation and Uses |
| 08/14/2008 | US20080194633 E.g., [(1-(2-aminoacetyl)-4-{N-[(3-fluoro-2-methylphenyl)methyl]carbamoyl}(4-piperidyl))methoxy]-N-(4-ethylphenyl)carboxamide; smooth muscle myosin or non-muscle myosin modulator; hypotensive agent; asthma, COPD, bronchoconstrictive disease, glaucoma, pre-menstrual cramps, erectile dysfunction |
| 08/14/2008 | US20080194621 Substituted 4-phenyltetrahydroisoquinolines, process for their preparation, pharmaceutical compositions and therapeutic use |
| 08/14/2008 | US20080194539 Phenyl Diazepane Carboxamides and Annelated Phenyl Piperazine Carboxamides Containing Oxygen and Used as Dopamine D3 Antagonists |
| 08/14/2008 | US20080193521 Hyperphosphatemia in chronic kidney disease or end-stage renal disease patients; nutritional supplements |
| 08/14/2008 | US20080193443 Using connective tissue growth factor specific immunoglobulin for diagnosis, prevention and treatment of autosomal dominant polycystic kidney disease (ADPKD) |
| 08/14/2008 | CA2678193A1 Aza-bridged-ring compound |
| 08/14/2008 | CA2677661A1 Tricyclic compounds |
| 08/13/2008 | EP1956020A2 1-[2-(heterocyclyl-aminomethyl)-piperidin-1-YL]-1-(2-methyl-5-phenyl-heterocyclyl)-methanone derivatives and related compounds as orexin-1 antagonists for the treatment of obesity |
| 08/13/2008 | EP1956001A1 Pharmaceutical for use in the treatment of ureterolithiasis |
| 08/13/2008 | EP1954677A1 Thiomorpholine compound and process for preparing the same |
| 08/13/2008 | EP1954273A1 Treatment of stress urinary incontinence and mixed urinary incontinence |
| 08/13/2008 | EP1954270A1 Rapamycin derivative or an impdh inhibitor for treating polycystic kidney disease |
| 08/13/2008 | EP1572632B1 Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists |
| 08/13/2008 | EP1501803B1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 08/13/2008 | EP1467979B1 Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function |
| 08/13/2008 | EP1452528B1 Xanthine oxidase inhibitors |
| 08/13/2008 | EP1427379B1 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
| 08/13/2008 | EP1322309B1 High affinity small molecule c5a receptor modulators |
| 08/13/2008 | CN101242850A Composition, function and use of xanthoceras sorbifolia extract and compound isolated from same, method for preparing same |
| 08/13/2008 | CN101240017A A uro-genital disease treatment system |
| 08/13/2008 | CN101240000A Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 08/13/2008 | CN101239186A Use of soluble lymphotoxin-beta receptors |
| 08/13/2008 | CN101239179A Non-aqueous polar aprotic peptide formulations |
| 08/13/2008 | CN101239123A Medicaments for treating renal failure |
| 08/13/2008 | CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 08/13/2008 | CN100410245C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/13/2008 | CN100409893C Medicine for treating functional renal failure and preparation method thereof |
| 08/13/2008 | CN100409837C Shenkang freeze-dried powder injection for injection and its preparation technology |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7410991 Pyrazolidinone compounds as ligands of the prostaglandin EP2 and/or EP4 receptors |
| 08/12/2008 | US7410946 Method for treating damage in intact skin comprising administering a composition comprising basic milk growth factors in amounts higher than those in milk |
| 08/12/2008 | US7410644 Recombinant pox virus for immunization against tumor-associated antigens |
| 08/12/2008 | US7410642 Assays and therapies for latent viral infection |
| 08/12/2008 | US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders |
| 08/12/2008 | CA2504517C Adsorbent for oral administration, and agent for treating or preventing renal or liver disease |
| 08/12/2008 | CA2504514C Adsorbent for oral administration |
| 08/12/2008 | CA2350786C Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| 08/12/2008 | CA2184828C Composition for inactivating irritants in fluids |
| 08/07/2008 | WO2008094037A1 The use of alkaline phosphatase in the treatment of reduced renal function |
| 08/07/2008 | WO2008093838A1 Pyridyl imidazolidine derivative having sulfamoyl group, and pharmaceutical use thereof |
| 08/07/2008 | WO2008093767A1 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
| 08/07/2008 | WO2008093737A1 Amide derivative |